Janet Wood­cock to be act­ing FDA com­mis­sion­er while Biden team fi­nal­izes nom­i­nee — re­ports

Janet Wood­cock is set to be the most pow­er­ful per­son at the FDA in less than a week.

The vet­er­an reg­u­la­tor and long­time di­rec­tor of the Cen­ter for Drug Eval­u­a­tion and Re­search has been tapped as act­ing com­mis­sion­er of the FDA, ac­cord­ing to re­ports by Bio­Cen­tu­ry’s Steve Us­din and Pink Sheet’s Sarah Kar­lin-Smith.

The ap­point­ment was re­quest­ed by the in­com­ing Biden team, Kar­lin-Smith added, as they sort out the nom­i­na­tion of a per­ma­nent suc­ces­sor to Stephen Hahn — whose one-year tenure has been de­fined by Covid-19.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER